BCDA
BioCardia, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
BioCardia (BCDA) Stock: Buy, Sell, or Hold?
$0.92
-0.01 (-0.91%)
▼
5d:
+0.94%
30d:
-6.93%
90d:
-0.78%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (87%)
Quality Score
57/100
Position
FAIR
30-Day Fair Range
$0.89 – $1.02
Position: FAIR
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$15.50
+1581.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.84 / $1.00
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: BCDA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Get Alerted When BCDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BCDA is currently trading at $0.92, which is considered fair relative to its 30-day fair value range of $0.89 to $1.02.
Technical Outlook: Technically, BCDA is showing sideways momentum. Immediate support is located at $0.84, while resistance sits at $1.00.
Market Sentiment: BCDA scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+1581.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCDA is showing sideways momentum. Immediate support is located at $0.84, while resistance sits at $1.00.
Market Sentiment: BCDA scores 71/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+1581.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.89 -
$1.02
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$0.89 -
$1.02
Current vs Trading Range
FAIR
Support Level
$0.84
Resistance Level
$1.00
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (71/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1581.7% below Wall St target ($15.50)
- BULLISH: Bottoming setup score 71/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-1.59
Wall Street Target
$15.50
(+1581.7%)
Revenue Growth (YoY)
-100.0%
Share BCDA Analysis
Share this live BCDA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCDA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message suggests that BioCardia ($BCDA) is undervalued despite major firms selling off, and that potential catalysts justify a buy position.
Key Retail Themes:
Undervalued stock
Potential catalysts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:04 AM ET
Data refreshes hourly during market hours. Next update: 10:04 AM
Data refreshes hourly during market hours. Next update: 10:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
PALI
Palisade Bio Inc |
STRONG BUY
10 analysts |
$10 | 62 BUY |
|
ZYME
Zymeworks Inc. Common St… |
STRONG BUY
14 analysts |
$42 | 42 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCDA Research Pages